17-28610590-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001174103.2(RSKR):āc.1121T>Gā(p.Val374Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000195 in 1,535,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001174103.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RSKR | NM_001174103.2 | c.1121T>G | p.Val374Gly | missense_variant | 12/12 | ENST00000301037.11 | NP_001167574.1 | |
SPAG5-AS1 | NR_040012.1 | n.273-5695A>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RSKR | ENST00000301037.11 | c.1121T>G | p.Val374Gly | missense_variant | 12/12 | 5 | NM_001174103.2 | ENSP00000301037.5 | ||
ENSG00000258472 | ENST00000531839.5 | c.524+2441T>G | intron_variant | 2 | ENSP00000431165.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152054Hom.: 0 Cov.: 31
GnomAD4 exome AF: 7.23e-7 AC: 1AN: 1383844Hom.: 0 Cov.: 31 AF XY: 0.00000146 AC XY: 1AN XY: 682868
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152054Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 16, 2024 | The c.1121T>G (p.V374G) alteration is located in exon 12 (coding exon 12) of the SGK494 gene. This alteration results from a T to G substitution at nucleotide position 1121, causing the valine (V) at amino acid position 374 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at